Wealthcare Advisory Partners LLC Innoviva, Inc. Transaction History

Wealthcare Advisory Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$11.45 - $13.96 $13,740 - $16,752	-1,200 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$11.06 - $12.87 $13,272 - $15,443	1,200 New	1,200 $14,000
Q2 2020 Jul 29, 2020	SELL	$11.49 - $15.26 $13,788 - $18,312	-1,200 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.44 - $17.59 $16,128 - $21,108	1,200 New	1,200 $17,000

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.